-
Je něco špatně v tomto záznamu ?
Effect of Laparoscopic Sleeve Gastrectomy on Serum Adipokine Levels
Ľ. Cibičková, M. Grega, R. Dohnal, J. Schovánek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- adipokiny MeSH
- adiponektin MeSH
- gastrektomie metody MeSH
- hmotnostní úbytek fyziologie MeSH
- inzulinová rezistence * fyziologie MeSH
- laparoskopie * metody MeSH
- LDL-cholesterol MeSH
- leptin MeSH
- lidé MeSH
- morbidní obezita * metabolismus chirurgie MeSH
- resistin MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Bariatric procedures are considered to be the most effective treatment options for obesity. One of them is laparoscopic sleeve gastrectomy (LSG), which is nowadays very popular and widely used. LSG leads to weight loss and metabolic improvement and also changes adipokine levels, although it is just a restrictive operation. We describe changes in pro-inflammatory (leptin, resistin, visfatin and chemerin) and anti-inflammatory adipokines (adiponectin, omentin), with adiponectin and leptin being most studied. Their levels are markedly changed after LSG and this may partially explain the weight loss seen after LSG. Adipokines are closely connected to insulin resistance and chronic inflammation both being positively influenced after LSG. Leptin regulates amount of body fat, appetite, thermogenesis and metabolic rate and its levels are positively correlated with both weight and BMI changes after operation. Resistin influences insulin sensitivity, modulates body cholesterol trafficking and its changes after operation correlate with BMI, waist circumference, fat mass, LDL cholesterol and C-reactive protein. Chemerin, an important component of immune system, decreases after bariatric surgery and its levels correlate with BMI, triglyceride levels, and blood glucose. On the other hand, pro-inflammatory adipokine adiponectin, which influences fatty acid oxidation, browning of fat tissue and energy metabolism, is declining after LSG. This decline explains improvement of glucose status after bariatric surgery in patients with diabetes and is correlated with BMI loss, waist circumference and LDL cholesterol level. Effect of LSG goes beyond calory restriction and the changes of adipokines have a great impact on health status of the bariatric patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23013868
- 003
- CZ-PrNML
- 005
- 20231011093632.0
- 007
- ta
- 008
- 230907s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935053 $2 doi
- 035 __
- $a (PubMed)37565420
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Cibičková, Ľubica $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0224082 $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
- 245 10
- $a Effect of Laparoscopic Sleeve Gastrectomy on Serum Adipokine Levels / $c Ľ. Cibičková, M. Grega, R. Dohnal, J. Schovánek
- 520 9_
- $a Bariatric procedures are considered to be the most effective treatment options for obesity. One of them is laparoscopic sleeve gastrectomy (LSG), which is nowadays very popular and widely used. LSG leads to weight loss and metabolic improvement and also changes adipokine levels, although it is just a restrictive operation. We describe changes in pro-inflammatory (leptin, resistin, visfatin and chemerin) and anti-inflammatory adipokines (adiponectin, omentin), with adiponectin and leptin being most studied. Their levels are markedly changed after LSG and this may partially explain the weight loss seen after LSG. Adipokines are closely connected to insulin resistance and chronic inflammation both being positively influenced after LSG. Leptin regulates amount of body fat, appetite, thermogenesis and metabolic rate and its levels are positively correlated with both weight and BMI changes after operation. Resistin influences insulin sensitivity, modulates body cholesterol trafficking and its changes after operation correlate with BMI, waist circumference, fat mass, LDL cholesterol and C-reactive protein. Chemerin, an important component of immune system, decreases after bariatric surgery and its levels correlate with BMI, triglyceride levels, and blood glucose. On the other hand, pro-inflammatory adipokine adiponectin, which influences fatty acid oxidation, browning of fat tissue and energy metabolism, is declining after LSG. This decline explains improvement of glucose status after bariatric surgery in patients with diabetes and is correlated with BMI loss, waist circumference and LDL cholesterol level. Effect of LSG goes beyond calory restriction and the changes of adipokines have a great impact on health status of the bariatric patients.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a adipokiny $7 D054392
- 650 _2
- $a leptin $7 D020738
- 650 _2
- $a resistin $7 D052243
- 650 _2
- $a adiponektin $7 D052242
- 650 _2
- $a LDL-cholesterol $7 D008078
- 650 12
- $a inzulinová rezistence $x fyziologie $7 D007333
- 650 12
- $a laparoskopie $x metody $7 D010535
- 650 _2
- $a gastrektomie $x metody $7 D005743
- 650 _2
- $a hmotnostní úbytek $x fyziologie $7 D015431
- 650 12
- $a morbidní obezita $x metabolismus $x chirurgie $7 D009767
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Grega, Michal $7 xx0307845 $u Internal Department, Hospital Vítkovice, Czech Republic
- 700 1_
- $a Dohnal, Roman $7 xx0274508 $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Schovánek, Jan $7 xx0227659 $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $u Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl 2 (2023), s. S165-S172
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37565420 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230907 $b ABA008
- 991 __
- $a 20231011093628 $b ABA008
- 999 __
- $a ok $b bmc $g 1991295 $s 1200178
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c Suppl 2 $d S165-S172 $e 2023Jul31 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230907